Open access · Peer reviewed · No APCs
Case ReportJournal of Pharmacology and PharmacotherapeuticsVol. 5 | Issue 2 | 2014 | pp. 161–162Open access
Tumor lysis syndrome in multiple myeloma treated with bortezomib
- 1*,
- 1
- 1 Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report.
Published in Journal of Pharmacology and Pharmacotherapeutics
Correspondence: K. M. Dhanraj
Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report.
Email: dhannu_doc@rediffmail.com
Copyright: © 2014 Manuscript Technomedia LLP. This is an open access article.
- Published:
- Jan 1, 2014
- Received:
- Feb 17, 2013
- Accepted:
- Oct 6, 2013
How to cite
Dhanraj, K. M., & Biswajit, D. (2014). Tumor lysis syndrome in multiple myeloma treated with bortezomib. Journal of Pharmacology and Pharmacotherapeutics, 5(2), 161–162. https://doi.org/10.4103/0976-500X.130091
Abstract
A 65 year old male diagnosed as multiple myeloma was started on bortezomib developed tumor lysis syndrome. Bortezomib induced tumor lysis is rare and suitable precautions should be considered in these patients.
Keywords
Subject
Article metadata
| Title | Tumor lysis syndrome in multiple myeloma treated with bortezomib |
|---|---|
| Authors | K. M. Dhanraj; Dubashi Biswajit |
| Affiliations | Department of Medical Oncology, Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), Pondicherry, India Case Report. |
| Corresponding author | dhannu_doc@rediffmail.com |
| Journal | Journal of Pharmacology and Pharmacotherapeutics |
| Volume / Issue | Vol. 5, Issue 2 (2014) |
Also in this issue
- Why patients in pain cannot get “God’s own medicine?”pp. 81–2
- Switch over from intravenous to oral therapy: A concise overviewpp. 83–87
- Off‑label use of medicine: Perspective of physicians, patients, pharmaceutical companies and regulatory authoritiespp. 88–92
- Folic acid supplementation on homocysteine levels in children taking antiepileptic drugs: A randomized controlled trialpp. 93–94
- Identification of risk factors for carbamazepine‑induced serious mucocutaneous adverse reactions: A case‑control study using data from spontaneous adverse drug reaction reportspp. 100–138
Readers Also Viewed
Development and Validation of UV/visible Spectrophotometric Method for Estimation of Piroxicam from Bulk and Formulation
Sandip Mohan Honmane, Kunal Rajaram Yadav, Yuvraj Dilip Dange
Apr 23, 2025
Effects of Artificial Intelligence on Academic Performance of Library and Information Science University Students: A Meta-Analysis (2023-2025)
Kayode Sunday John Dada
Aug 6, 2026
Bridging Innovation and Impact: A Multidisciplinary Approach to Contemporary Research Challenges
Mueen Ahmed KK
Aug 11, 2026